期刊文献+

药物斑贴试验与药疹 被引量:1

Drug patch testing and drug eruption
原文传递
导出
摘要 药疹是指正常剂量的药物经过多种途径进入人体后引起的皮肤黏膜的损害,其病理生理学发病机制不明.药疹的临床表现多样,了解药疹的分类及发病机制对其诊断和寻找可疑致敏药物至关重要.药物斑贴试验的目的是寻找引起药疹的致敏药物,提供患者可能的致敏药物信息.近年来应用于临床的药物斑贴试验安全性较高、操作简便,为药疹的诊断提供了重要的依据.有关药物斑贴试验的相关研究较多,但结果不一. Drug eruption refers to adverse reactions of skin and mucous membrane caused by the entry of drugs at normal doses into the human body through multiple ways.The pathophysiology of drug eruption is unclear.The manifestations of drug eruption are various.To learn the classification and pathogenesis of drug eruption is important for its diagnosis and identification of the culprit drug.The purpose of drug patch testing is to find drug allergens,and to provide patients with possible information about causative drugs.At present,the drug patch testing applied in clinical practice are relatively safe and convenient,which has offered an important basis for the diagnosis of drug eruption.There have been numerous studies on drug patch testing,but the results are varying and somewhat contradictory.
出处 《国际皮肤性病学杂志》 2014年第4期240-242,共3页 International Journal of Dermatology and Venereology
基金 卫生公益性行业科研专项经费项目(201002016)
关键词 药疹 斑片试验 外用药 Drug eruptions Patch tests External application drugs
  • 相关文献

参考文献16

  • 1Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patcb tests for tbe three main classes of severe cutaneous adverse drug reactions [J]. BrJ Dennatol, 2013,168(3): 555-562.
  • 2Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes[J] Clin Biochem Rev, 2013, 34(1): 15-38.
  • 3Liippo J, Pummi K, Hohenthal U, et al. Patch testing and sensitization to multiple drugs [J]. Contact Dermatitis, 2013, 69 (5): 296-302.
  • 4Jachiet M, Bellon N, Assier H, et al. Cutaneous adverse drug reaction to oral acetazolamide and skin tests [J]. Dermatology, 2013, 226(4): 347-352.
  • 5Santiago F, Concalo M, Vieira R, et al. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS) [J]. Contact Dermatitis, 2010, 62(1): 47-53.
  • 6Sdnchez-Morillas L, Rojas Perez-Ezquerra P, Gonzalez Morales ML, et al. Fixed drug eruption due to ibuprofen with patch test positive on the residual lesion [J]. Allergol Immunopathol, 2013, 41(3): 203-204.
  • 7Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity[J]. Br J Dennatol, 2005, 152(5): 968-974.
  • 8Britschgi M, Steiner UC, Schmid S, et aI. T-cell involvement in drug-induced acute generalized exanthematous pustulosis [J]. J Clin Invest, 2001,107(11): 1433-1441.
  • 9Wolkenstein P, Chosidow 0, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including StevensJohnson syndrome and toxic epidermal necrolysis [J]. Contact Dermatitis, 1996, 35(4): 234-236.
  • 10Mashiah J, Brenner S. A systemic reaction to patcb testing for the evaluation of acute generalized exanthematous pustulosis [J]. Arch Dermatol, 2003, 139(9): ll81-ll83.

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部